Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Pharmaceuticals

    Pharmaceuticals - Page 54

    Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study

    Biohaven Pharma Alzheimers treatment Troriluzole to continue late-stage study

    Medical Dialogues Bureau11 Dec 2019 9:00 AM IST
    Biohaven Pharmaceutical's study of its experimental Alzheimer's treatment, Troriluzole is being led by the Alzheimer's Disease Cooperative Study...
    Roche secures CE Mark for Accu-Chek SugarView app for diabetes management

    Roche secures CE Mark for Accu-Chek SugarView app for diabetes management

    Farhat Nasim10 Dec 2019 1:07 PM IST
    Now officially classified as in-vitro diagnostics (IVD) software, the app will be made widely accessible by Roche first for certain smartphone models...
    Dr Reddys unveils generic Deferasirox Tablets in US

    Dr Reddys unveils generic Deferasirox Tablets in US

    Farhat Nasim10 Dec 2019 12:53 PM IST
    The two different products launched by Dr Reddy's Labs in the US market are generic versions of Exjade (deferasirox) and Jadenu (deferasirox)...
    With Vildagliptin off-patent from today, new doors open for pharma players

    With Vildagliptin off-patent from today, new doors open for pharma players

    Farhat Nasim10 Dec 2019 12:47 PM IST
    New Delhi: The expiry of Swiss-drugmaker Novartis's blockbuster anti-diabetic drug Vildagliptin is being a bringer of glad tidings for Indian Pharma...
    Sanofi to acquire biotech firm Synthorx for USD 2.5 billion

    Sanofi to acquire biotech firm Synthorx for USD 2.5 billion

    Medical Dialogues Bureau10 Dec 2019 11:15 AM IST
    "This acquisition ... is aligned with our goal to build our oncology franchise with potentially practice-changing medicines and novel combinations,"...
    Grifols Alzheimers trial shows positive results

    Grifols Alzheimers trial shows positive results

    Medical Dialogues Bureau10 Dec 2019 9:00 AM IST
    The latest results strengthen Grifols' research on plasma protein replacement therapies, the company said.New Delhi: Spain's Grifols said on Friday...
    Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation

    Sun Pharma arm-SPARC updates on Paclitaxel Injection Concentrate for Suspension litigation

    Farhat Nasim9 Dec 2019 3:56 PM IST
    "Abraxis Biosciences LLC has dismissed the patent infringement complaint filed against Sun Pharma Advanced Research Co Ltd regarding SPARC's New Drug...
    Solara Active Pharma names Bharath R Sesha as new CEO

    Solara Active Pharma names Bharath R Sesha as new CEO

    Farhat Nasim9 Dec 2019 3:15 PM IST
    "The Board of Directors, on the recommendation of Nomination and Remuneration Committee, have appointed Bharath R Sesha as Chief Executive Officer of...
    Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval

    Amgen biosimilar to JnJ arthritis drug Remicade gets USFDA approval

    Medical Dialogues Bureau9 Dec 2019 1:00 PM IST
    Amgen Inc's biosimilar, Avsola, has the same chemical components, dosage form and strength as Remicade and would treat a range of autoimmune...
    CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

    CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

    Farhat Nasim9 Dec 2019 12:12 PM IST
    The direction to submit PSURs came after various stakeholders of Veterinary products raised a concern regarding the clarification with respect to...
    GAVI to invest USD 178 million for creating Ebola vaccine stockpile

    GAVI to invest USD 178 million for creating Ebola vaccine stockpile

    Farhat Nasim9 Dec 2019 9:30 AM IST
    Since the latest outbreak in Congo was identified last August, health officials have immunised more than 255, 000 people with a recently licensed...
    Bristol-Myers, bluebird cancer therapy meets goal in mid-stage trial

    Bristol-Myers, bluebird cancer therapy meets goal in mid-stage trial

    Medical Dialogues Bureau9 Dec 2019 9:15 AM IST
    The study evaluated the efficacy and safety of the therapy, Ide-cel, in patients who had received three prior treatments for multiple myeloma, a...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Government appoints 108 drug inspectors pan India; Details

    Government appoints 108 drug inspectors pan India; Details

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    Mediclaim cannot be rejected if duplicate bills are submitted: Consumer Forum on doctors plea

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok